Default object view. Click to create a custom template, Node ID: 179599, Object ID: 107387

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansi...

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

No relation

Yes

No relation

No

25/04/2017 3:21 pm

No